Acciones Tetra Bio Pharma Inc Canadian Securities Exchange
Acciones
TBP
CA88166Y1007
Farmacéuticos
Ventas 2020 | - | Ventas 2021 | - | Capitalización | 88,81 M 121 M 81,5 M |
---|---|---|---|---|---|
Resultado Neto 2020 | -26 M -35,54 M -23,86 M | Resultado Neto 2021 | -52 M -71,09 M -47,72 M | VE / Ventas 2020 | - |
Posición de caja neta 2020 | 501 mil 684 mil 459 mil | Posición de caja neta 2021 | 1,77 M 2,43 M 1,63 M | VE / Ventas 2021 | - |
P/E ratio 2020 |
-1,86
x | P/E ratio 2021 |
-1,7
x | Empleados | - |
Rendimiento 2020 * |
-
| Rendimiento 2021 |
-
| Flotante | 99,01 % |
Directores | Puesto | Edad | Desde |
---|---|---|---|
Guy Chamberland
CEO | Chief Executive Officer | - | 01/06/16 |
Natalie Leroux
IRC | Investor Relations Contact | - | - |
Michael Olders
PRN | Corporate Officer/Principal | - | - |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Guy Chamberland
CEO | Chief Executive Officer | - | 01/06/16 |
Catherine Auld
BRD | Director/Board Member | - | 28/05/21 |
H. Norton
CHM | Chairman | 63 | 17/09/20 |
Varia. 1 de ene. | Capi. | |
---|---|---|
+9,94 % | 4989,65 M | |
-32,21 % | 3608,74 M | |
-1,43 % | 3097,42 M | |
-25,09 % | 2642,1 M | |
-11,46 % | 2316,45 M | |
+36,65 % | 1846,98 M | |
+37,15 % | 1430,89 M | |
-16,01 % | 1389,27 M | |
+40,95 % | 1372,32 M |